Influence of lipid profile and statin administration on arterial stiffness in renal transplant recipients

BACKGROUND: Hyperlipidemia is one of the major risk factors for developing a cardiovascular disease (CVD) and it is a frequent post-transplant complication, occurring in up to 60% of the renal transplant recipients (RTRs). Lipid lowering therapy with HMG-CoA reductase inhibitors (statins) is general...

Descripción completa

Detalles Bibliográficos
Autores principales: Heleniak, Zbigniew T., Illersperger, Sarah, Brakemeier, Susanne, Dębska-Ślizień, Alicja, Bach, Paul, Budde, Klemens, Halleck, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007483/
https://www.ncbi.nlm.nih.gov/pubmed/32329037
http://dx.doi.org/10.5603/CJ.a2020.0063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007483/
https://www.ncbi.nlm.nih.gov/pubmed/32329037
http://dx.doi.org/10.5603/CJ.a2020.0063

Ejemplares similares